K2 Principal Fund, L.P. Aurinia Pharmaceuticals Inc. Put Options Transaction History

K2 Principal Fund, L.P.

5 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2020 Aug 13, 2020	SELL	$14.12 - $18.33 $1.57 Million - $2.03 Million	-111,000 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$3.88 - $21.42 $430,680 - $2.38 Million	111,000 New	111,000 $2.25 Million
Q1 2018 May 14, 2018	SELL	$4.85 - $5.99 $58,199 - $71,880	-12,000 Closed	0 $0
Q4 2017 Feb 12, 2018	SELL	$4.53 - $7.09 $112,797 - $176,541	-24,900 Reduced 67.48%	12,000 $54,000
Q3 2017 Nov 09, 2017	BUY	$5.71 - $6.9 $210,699 - $254,610	36,900	36,900 $231,000

210

58.1M

1.14M

1.51M

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.13B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

Get notified when there are updates to the investment portfolio of K2 Principal Fund, L.P., based on Form 13F filings with the SEC.

Stay updated on K2 Principal Fund, L.P. with notifications on news.